Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sven R. Suwijn"'
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 10, Iss , Pp 100241- (2024)
Externí odkaz:
https://doaj.org/article/b786d0446aa645f28fd96c1ad71427d1
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-5 (2019)
Abstract Purpose To determine the reliability of visual assessment of [123I]FP-CIT SPECT imaging by non-experts in dopamine transporter (DAT) SPECT imaging in patients with early drug-naive Parkinson’s disease (PD). Also, we explored the indication
Externí odkaz:
https://doaj.org/article/d51f52bd73ba43e18edbf560eba1c703
Autor:
Alberto J. Espay, Sven R. Suwijn, Susan H. Fox, Hein J. Verberne, Monty Silverdale, Michael Samuel, Joke M. Dijk, Jan Booij, Carsten Eggers, Hamdia Samim, Constant V. M. Verschuur, Rob M.A. de Bie, Anthony E. Lang
Publikováno v:
Journal of Parkinson's Disease
Journal of Parkinson s disease, 10(4), 1561-1569. IOS Press
Journal of Parkinson s disease, 10(4), 1561-1569. IOS Press
Background: In clinical trials that recruited patients with early Parkinson’s disease (PD), 4–15% of the participants with a clinical diagnosis of PD had normal dopamine transporter single photon emission computed tomography (DAT SPECT) scans, al
Autor:
Henrieke L, Frequin, Jason, Schouten, Constant V M, Verschuur, Sven R, Suwijn, Judith A, Boel, Bart, Post, Bastiaan R, Bloem, Johannes J, van Hilten, Teus, van Laar, Gerrit, Tissingh, Alexander G, Munts, Joke M, Dijk, Günther, Deuschl, Anthony, Lang, Marcel G W, Dijkgraaf, Rob J, de Haan, Rob M A, de Bie
Publikováno v:
Neurology.
The Levodopa in EArly Parkinson´s disease (LEAP) study enabled us to conduct post-hoc analyses concerning the effects of levodopa in patients with early Parkinson's disease.The LEAP-study was a double-blind, placebo-controlled, randomized, delayed-s
Publikováno v:
EJNMMI research, 9(1):63. Springer Berlin
EJNMMI Research, Vol 9, Iss 1, Pp 1-5 (2019)
EJNMMI Research, Vol 9, Iss 1, Pp 1-5 (2019)
Purpose To determine the reliability of visual assessment of [123I]FP-CIT SPECT imaging by non-experts in dopamine transporter (DAT) SPECT imaging in patients with early drug-naive Parkinson’s disease (PD). Also, we explored the indications of DAT
Publikováno v:
Neurology, 86(15). Lippincott Williams and Wilkins
A 30-year-old man presented with 3 months of alternating hyper- and hypothermia, libido loss, hypersomnia, and headache. Neurologic examination was unremarkable. Laboratory tests revealed low serum testosterone and hypocortisolism. MRI showed hypotha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1369d433b8c7724978512d0838905c2e
https://pure.amc.nl/en/publications/antima2associated-encephalitis-in-a-patient-with-testis-carcinoma(e59461d3-7b25-4b3a-939d-53efd276acfa).html
https://pure.amc.nl/en/publications/antima2associated-encephalitis-in-a-patient-with-testis-carcinoma(e59461d3-7b25-4b3a-939d-53efd276acfa).html
Publikováno v:
Parkinsonism & related disorders, 20(Suppl. 1), S184-S186. Elsevier BV
Imaging of the dopaminergic system with single photon emission computed tomography (SPECT), and particularly of the dopamine transporter (DAT) located in the striatum, is a well accepted tool in clinical practice to confirm or exclude loss of nigrost
Autor:
Caroline J. M. van Boheemen, Gerrit Tissingh, Sven R. Suwijn, Jan Booij, Rob M.A. de Bie, Rob J. de Haan
Publikováno v:
EJNMMI Research
In specialized movement disorder centers, Parkinson’s disease (PD) is wrongly diagnosed in 6 to 25% of cases. To improve the accuracy of the clinical diagnosis, it is necessary to have a reliable and practical reference standard. Dopamine transport
SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
Autor:
A. Winogrodzka, Jan Booij, Sven R. Suwijn, Constant V. M. Verschuur, Rob M.A. de Bie, Henk W. Berendse
Publikováno v:
EJNMMI Research
EJNMMI research, 3(1). Springer Berlin
Suwijn, S R, Berendse, H W, Verschuur, C V, Winogrodzka, A, de Bie, R M & Booij, J 2013, ' SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias ', EJNMMI Research, vol. 3, no. 1, pp. 44 . https://doi.org/10.1186/2191-219X-3-44
EJNMMI Research, 3(1). Springer Berlin
EJNMMI research, 3(1). Springer Berlin
Suwijn, S R, Berendse, H W, Verschuur, C V, Winogrodzka, A, de Bie, R M & Booij, J 2013, ' SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias ', EJNMMI Research, vol. 3, no. 1, pp. 44 . https://doi.org/10.1186/2191-219X-3-44
EJNMMI Research, 3(1). Springer Berlin
Background: Although the treatment of Parkinson's disease (PD) is very effective, in the course of the disease, 40% to 60% of patients develop dyskinesias. The pathophysiology of dyskinesias is still unclear. Results of preclinical research suggest t
Autor:
Bart Post, Günther Deuschl, van Teus Laar, R.J. de Haan, R. M. A. de Bie, Sven R. Suwijn, Gerrit Tissingh, Anthony E. Lang, Constant V. M. Verschuur, J.J. van Hilten, Marcel G. W. Dijkgraaf, B.R. Bloem
Publikováno v:
BMC Neurology, 15
BMC Neurology, 15, 236
BMC neurology, 15(1). BioMed Central
BMC NEUROLOGY, 15:236. BioMed Central Ltd.
BMC Neurology
BMC Neurology, 15, 1, pp. 236
BMC Neurology, 15, 236
BMC neurology, 15(1). BioMed Central
BMC NEUROLOGY, 15:236. BioMed Central Ltd.
BMC Neurology
BMC Neurology, 15, 1, pp. 236
Contains fulltext : 152630.pdf (Publisher’s version ) (Open Access) BACKGROUND: The aim of this study is to investigate if early treatment with levodopa has a beneficial disease modifying effect on Parkinson's disease (PD) symptoms and functional h